Benjamin Kyle Scholl

Max Planck Florida Corporation

$1,668,039

Attributed

$1,958,381

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $585.2K · FY2020–25

$1M$750K$500K$250K$0

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$1,958,381 · 4

By mechanism

R00$966,914 · 1

R21$438,750 · 1

R34$336,935 · 1

K99$215,782 · 1

Top collaborators

Diego Contreras1 shared
Alexander C Huk1 shared

Most similar at Max Planck Florida Corporation

Same institution · by research overlap

David Fitzpatrick$19,898,000
Jason M Christie$11,618,496
Hyungbae Kwon$9,091,220

Others in their field

Other Emerging Leaders on “In Vivo”

Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
Lynn Briscoe · Leidos Biomedical Research, Inc.$94,216,744
Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
John Damon Chodera · Sloan-Kettering Inst Can Research$43,427,103
Tony Moody · Duke University$34,777,314
Alan D. Palkowitz · Indiana University Indianapolis$18,925,366

Research focus

In VivoSignal TransductionNeuronsVisual CortexCellsFerretsPrimatesPhysiologySchizophreniaSensoryElectrophysiology (Science)Biological ModelsExperimental StudyInnovationSynapsesRodentPresynapticInsightNeocorticalVisualImpairmentInhibitory NeuronImagePositioning Attribute